NEW YORK (GenomeWeb News) – Analytical instrument firm Leco announced today an agreement with the US Department of Energy's Lawrence Berkeley National Laboratory to develop metabolomic applications and tools.
The deal provides Berkeley Lab's Life Sciences Division access to Leco's Citius LC-High Resolution TOF-MS. The instrument provides acquisition speeds of up to 200 spectra per second, mass resolution up to 100,000 full width at half maximum (FWHM) and mass accuracy less than 1 parts per million, Leco said.
Trent Northen, a staff scientist at Berkeley Labs Life Sciences Division and the Joint BioEnergy Institute, will direct the research, which focuses on constructing detailed models of cellular communities' metabolism and energy. Metabolite imaging and metabolomic analysis will be conducted to build the models, and applications of the research will go toward elucidating the dynamics of microbial communities and the metabolic drivers of breast cancer.
Terms of the deal were not disclosed.
Last week, Leco and Genedata announced an agreement to market Genedata Expressionist MSX software compatibility with Leco's HR TOF-MS instrument.